✦ LIBER ✦

De novo malignancies in liver transplantation

✍ Scribed by J.M Valero; E Rubio; J.M Moreno; F Pons; V Sanchez-Turrion; V Cuervas-Mons

Book ID: 117233196
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 82 KB
Volume: 35
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(03)00058-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

De Novo Posttransplantation Nonlymphopro

De Novo Posttransplantation Nonlymphoproliferative Malignancies in Liver Transplant Recipients

✍ I. Boin; M.I. Leonardi; R.B. Stucchi; E.C. Ataide; J.R. Almeida; R.H. Barros; L. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Burden of de novo malignancy in the live

Burden of de novo malignancy in the liver transplant recipient

✍ Chandok, Natasha; Watt, Kymberly D. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Risk factors and incidence of de novo ma

Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review

✍ Eric Chak; Sammy Saab 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Distribution of lymphocyte subtypes in l

Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy

✍ N Rayes; W.O Bechstein; S.G Tullius; N.C Nüssler; U Naumann; S Jonas; R Neuhaus; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Extensive Surveillance Promotes Early Di

Extensive Surveillance Promotes Early Diagnosis and Improved Survival of De Novo Malignancies in Liver Transplant Recipients

✍ Armin Finkenstedt; Ivo W. Graziadei; Wilhelm Oberaigner; Wolfgang Hilbe; Karin N 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

CD28 expression by peripheral blood lymp

CD28 expression by peripheral blood lymphocytes as a potential predictor of the development of de novo malignancies in long-term survivors after liver transplantation

✍ Emmanuel Boleslawski; Samia Ben Othman; Lynda Aoudjehane; Sandrine Chouzenoux; O 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

At present, no method is available for accurately monitoring the degree of immunosuppression induced by antirejection therapies. The aim of this study was to determine whether CD28 and CD38 expression by peripheral blood mononuclear cells could be useful in predicting the development of de novo mali